We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 255.00
Bid: 250.00
Ask: 260.00
Change: 5.00 (2.00%)
Spread: 10.00 (4.00%)
Open: 247.50
High: 255.00
Low: 255.00
Prev. Close: 250.00
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Apr 2021 18:11

RNS Number : 3582V
Team17 Group PLC
13 April 2021
 

13 April 2021

 

Team17 Group plc

("Team17", the "Group" or the "Company")

 

Director/PDMR shareholding

 

On 12 April 2021 the Company was notified by Link Market Services Trustees Limited (the "Trustee"), as the Trustee of the Team17 Group plc Share Incentive Plan (the "Plan"), that on 12 April 2021 it had purchased ordinary shares of £0.01 each in the Company ("Partnership Shares") on behalf of the persons discharging managerial responsibility as set out below:

 

PDMR

Partnership Shares purchased

Price

Matching Shares awarded

Price

Mark Crawford

20

£7.65

6

nil

 

Under the Plan, each participant may contribute up to £150 per month towards the purchase of Partnership Shares. Matching Shares are awarded on the basis of two Matching Shares for each Partnership Share purchased, but only for the first £25 of Partnership Shares purchased per month. The Matching Shares will vest on the third anniversary of award, subject to continued employment and the retention of the underlying Partnership Shares.

 

Details of the director's resulting holdings of Ordinary Shares and options over Ordinary Shares are as follows:

 

Name

Total No. of Options

No. of Ordinary Shares

Mark Crawford

20,093

6,868

 

 

Enquiries:

 

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Mark Crawford, Chief Financial Officer

 

via Vigo Communications

+44 (0)20 7390 0238

GCA Altium (Nominated Adviser)

Adrian Reed / Paul Lines

 

+44 (0)845 505 4343

Berenberg (Broker)

Chris Bowman / Toby Flaux / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0)20 3207 7800

Vigo Communications (Financial Public Relations)

Jeremy Garcia / Charlie Neish

team17@vigocomms.com

+44 (0)20 7390 0238

 

 

About Team17

Team17 is a leading games entertainment label and creative partner for independent ("indie") developers, focused on the premium, rather than free to play market, and creating games for the PC home computer market, the video games console market and the mobile and tablet gaming markets. Alongside developing the Company's own games in house ("first party IP"), Team17 also partners with independent developers across the globe to add value to their games in all areas of development and production alongside bringing them to market across multiple platforms for fixed percentage royalties ("third-party IP"). Since foundation in 1990, we have launched over 100 games, including the iconic Worms franchise, the Overcooked franchise, the Escapists franchise, Yooka-Laylee, Yoku's Island Express, My Time at Portia, Hell Let Loose and Blasphemous, making Team17 one of the most prolific developers and partners of games for the indie market.

 

Visit www.team17.com for more info.

EU Market Abuse Regulation

 

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities

a)

Name

Mark Crawford

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Team17 Group plc

b)

LEI

2138006EUUCCL4ZI5E51

4

Details of the transaction(s): sections to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

ISIN: GB00BYVX2X20

b)

Nature of the transaction

Partnership shares purchased on behalf of Mark Crawford by the Trustee

c)

Prices(s) and volume(s)

Price(s):

Volume(s)

£7.65

20

d)

Aggregated information

Not applicable

e)

Date of transaction

12 April 2021

f)

Place of the transaction

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKNBBABKDAQD
Date   Source Headline
16th Apr 20247:00 amRNSUnaudited Final Results 2023
12th Apr 20241:16 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSNotice of Analyst & Investor Meetings, FY Results
19th Mar 20243:29 pmRNSHoldings in Company
13th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 20248:58 amRNSNotice of Results
14th Feb 20241:00 pmRNSDirector/PDMR Shareholding
13th Feb 20244:28 pmRNSDirector/PDMR Shareholding
1st Feb 20241:10 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading Update
19th Jan 20243:01 pmRNSHolding(s) in Company
12th Jan 20244:53 pmRNSHolding(s) in Company
12th Jan 20243:04 pmRNSHolding(s) in Company
11th Jan 20243:23 pmRNSDirector/PDMR Shareholding
14th Dec 20239:15 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSDirector Dealings
27th Nov 20237:00 amRNSDirector Dealings
24th Nov 20237:00 amRNSTrading Update
15th Nov 20233:29 pmRNSHolding(s) in Company
13th Nov 20234:57 pmRNSDirector/PDMR Shareholding
30th Oct 20233:51 pmRNSHolding(s) in Company
18th Oct 202312:41 pmRNSHolding(s) in Company
11th Oct 20235:14 pmRNSDirector/PDMR Shareholding
21st Sep 20231:06 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.